28.07.10 Cerenis Therapeutics SA raised EUR40m in a Series C financing round from the French Government and existing investors. The company, based in Toulouse, France, and Ann Arbor, Michigan, said the money will be used to fund Phase 2...
more
27.07.10 Paris-based drug company Sanofi-Aventis appears to be considering spending more than US-$20 billion for Genzyme Corp., the Wall Street Journal reported citing informed circles. This would be the biggest biotech acquisition after...
more
23.07.10 Novagali Pharma, a French pharmaceutical company specialized in ophthalmology, has raised EUR22m in an IPO on Euronext Paris and a private placement to institutional investors. The company, which his located in the Génopôle...
more
22.07.10 Allschwil / Marseille - The Swiss biotech company Actelion pays EUR10m to get a first hand on French Trophos SA. The two companies entered a binding agreement whereby Actelion has time till the end of 2011 to decide over an...
more
10.07.10 Paris – This year’s third small IPO went out on the Alternext market of Euronext Paris this year, with molecular diagnostics company IntegraGen S.A. raising EUR6.7m through the sale of 800,149 shares at a8.40, giving it a...
more
